Jmjd2c facilitates the assembly of essential enhancer-protein complexes at the onset of embryonic stem cell differentiation by Tomaz, R.A. et al.
PDF hosted at the Radboud Repository of the Radboud University
Nijmegen
 
 
 
 
The following full text is a publisher's version.
 
 
For additional information about this publication click this link.
http://hdl.handle.net/2066/168889
 
 
 
Please be advised that this information was generated on 2017-12-06 and may be subject to
change.
STEM CELLS AND REGENERATION RESEARCH ARTICLE
Jmjd2c facilitates the assembly of essential enhancer-protein
complexes at the onset of embryonic stem cell differentiation
Rute A. Tomaz1, Jennifer L. Harman2, Donja Karimlou1, Lauren Weavers1, Lauriane Fritsch3, Tony Bou-Kheir1,
Emma Bell1, Ignacio del Valle Torres4, Kathy K. Niakan4, Cynthia Fisher5, Onkar Joshi6, Hendrik G. Stunnenberg6,
Edward Curry1, Slimane Ait-Si-Ali3, Helle F. Jørgensen2 and Véronique Azuara1,*
ABSTRACT
Jmjd2 H3K9 demethylases cooperate in promotingmouse embryonic
stem cell (ESC) identity. However, little is known about their
importance at the exit of ESC pluripotency. Here, we reveal that
Jmjd2c facilitates this process by stabilising the assembly of
mediator-cohesin complexes at lineage-specific enhancers.
Functionally, we show that Jmjd2c is required in ESCs to initiate
appropriate gene expression programs upon somatic multi-lineage
differentiation. In the absence of Jmjd2c, differentiation is stalled at an
early post-implantation epiblast-like stage, while Jmjd2c-knockout
ESCs remain capable of forming extra-embryonic endoderm
derivatives. Dissection of the underlying molecular basis revealed
that Jmjd2c is re-distributed to lineage-specific enhancers during
ESC priming for differentiation. Interestingly, Jmjd2c-bound
enhancers are co-occupied by the H3K9-methyltransferase G9a
(also known as Ehmt2), independently of its H3K9-modifying activity.
Loss of Jmjd2c abrogates G9a recruitment and further destabilises
loading of the mediator and cohesin components Med1 and Smc1a at
newly activated and poised enhancers in ESC-derived epiblast-like
cells. These findings unveil Jmjd2c and G9a as novel enhancer-
associated factors, and implicate Jmjd2c as a molecular scaffold for
the assembly of essential enhancer-protein complexes with an
impact on timely gene activation.
KEY WORDS: Jmjd2c (Kdm4c), Enhancers, Gene regulation,
Embryonic stem cells, Epiblast stem cells, Lineage specification
INTRODUCTION
Pluripotency, the ability of a cell to generate all somatic lineages, is
transiently acquired in vivo during mammalian pre-implantation
development. Upon blastocyst formation, pluripotent cells develop
within the inner cell mass (ICM), a mosaic of cells surrounded by an
extra-embryonic layer – the trophectoderm. By the time of
implantation, a second extra-embryonic lineage, the primitive
endoderm, emerges at the ICM surface. Concurrently, the ICM
maintains its pluripotency as it matures into the epiblast but
ultimately goes on to form the three primary germ layers and germ
cells upon gastrulation (Boroviak and Nichols, 2014; Rossant,
2008).
Pluripotent mouse embryonic stem cells (ESCs) are derived from
ICM cells, and can self-renew and faithfully maintain an
undifferentiated state in vitro in the presence of leukaemia inhibitory
factor (LIF) and serum components, while preserving their multi-
lineage differentiation capacity (Evans and Kaufman, 1981; Martin,
1981; Niwa et al., 1998; Ying et al., 2003). Most recently, stem cell
lines with similar lineage potential were established from other
developmental stages (Chung et al., 2006; Tesar, 2005), including a
number of post-implantation epiblast-derived stem cells (EpiSCs)
(Brons et al., 2007; Osorno et al., 2012; Tesar et al., 2007). While
ESCs are thought to represent an immature (pre-implantation) phase
of pluripotency, EpiSCs exist in a more advanced state on the verge of
differentiation (Nichols and Smith, 2009). Moreover, ESCs can stably
transit into self-renewing EpiSCs, acquiring characteristics of post-
implantation epiblast-like cells (Guo et al., 2009).
ESC abilities depend on the potent expression of self-renewal
genes and transcriptional priming of silent, lineage-affiliated genes
– a crucial balance of gene expression maintained through crosstalk
between transcriptional factors and chromatin regulators (Azuara
et al., 2006; Bernstein et al., 2006; Chen and Dent, 2014; Ng and
Surani, 2011; Stock et al., 2007). Remarkably, both active (ESC-
specific) and primed (lineage-specific) genes are expressed in a
heterogeneous manner, a feature long considered to be a hallmark of
ESC cultures that safeguards the swift response to differentiation
cues (Efroni et al., 2008; Torres-Padilla and Chambers, 2014). Yet,
it is now possible to derive and maintain ESCs with reduced
heterogeneity and transcriptional gene priming through chemical
inhibition of two differentiation-associated pathways, Mek and
Gsk3 (2i conditions), capturing a naïve pluripotent state in vitro
(Marks et al., 2012; Ying et al., 2008).
Gene promoter regions enriched in CpG islands and H3K4me3
function as genomic platforms for the recruitment of transcription
factors and co-regulators, as well as for the basal transcriptional
machinery (Deaton and Bird, 2011; Illingworth and Bird, 2009).
Moreover, distal DNA elements such as enhancers play a significant
role in potentiating gene expression being typically decorated by
H3K4me1 and bound by pioneer transcription factors (Calo and
Wysocka, 2013; Gibcus and Dekker, 2013; Spitz and Furlong,
2012). For example, the core pluripotency factor Oct4 was
commonly shown to mark both active and poised enhancers in
ESCs and EpiSCs (Buecker et al., 2014; Calo and Wysocka, 2013).
Enhancer activity and robust ESC-specific gene expression entail
long-range DNA interactions with the transcriptional apparatus atReceived 20 July 2016; Accepted 14 December 2016
1Institute of Reproductive and Developmental Biology, Faculty of Medicine,
Imperial College London, London W12 0NN, UK. 2Cardiovascular Medicine
Division, Department of Medicine, University of Cambridge, Cambridge CB2 0QQ,
UK. 3Centre National de la Recherche Scientifique CNRS - Université Paris Diderot,
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promoters, involving the cooperative action of mediator-cohesin
complexes (Kagey et al., 2010). Yet, relatively little is known about
the identity of proteins that stabilise the formation of such
assemblies.
Histone demethylases have emerged as key players in the control
of cell identity and development, mainly through modulation of the
chromatin environment of tissue-specific genes (Nottke et al.,
2009). Recently, additional roles for these molecules independent of
their enzymatic activity have been reported (Shpargel et al., 2012;
Wang et al., 2012; Yang et al., 2010), especially in regulating the
recruitment of Polycomb repressive complexes (PRC) and poised
RNA polymerase II to the promoter regions of developmental genes
in ESCs (Farcas et al., 2012; Wu et al., 2013). Jmjd2c (also known
as Kdm4c) is a member of the Jmjd2 gene family initially identified
as H3K9me2/3 and/or H3K36me2/3 histone demethylases (Chen
et al., 2006; Klose et al., 2006; Whetstine et al., 2006). Jmjd2c is
highly expressed in the early embryo and in ESCs (Boroviak et al.,
2015; Burton et al., 2013; Loh et al., 2007; Wang et al., 2010), and
RNA interference-mediated depletion of the protein was shown to
impair cleavage-stage development and ESC integrity, as well as
inhibiting somatic cell reprogramming (Das et al., 2014; Loh et al.,
2007; Wang et al., 2010). Jmjd2c-null ESCs and mice could,
however, be generated via gene trap approaches (Pedersen et al.,
2014), in agreement with functional redundancy between Jmjd2
gene family members to support cell proliferation and survival
(Pedersen et al., 2016). At the genomic level, Jmjd2c preferentially
targets H3K4me3-rich promoter regions of active and development-
associated genes in ESCs via its Tudor domains (Das et al., 2014;
Pedersen et al., 2014), where Jmjd2c is proposed to assist Jmjd2b-
Nanog and PRC2 in transcriptional activation and repression,
respectively (Das et al., 2014).
In this study, we uncover a previously unrecognised link between
Jmjd2c recruitment to lineage-specific enhancers and the
establishment of a functionally primed state for differentiation
in vitro. We show that, in the absence of Jmjd2c, ESC
differentiation is severely impeded at an early post-implantation
epiblast-like stage. Although Jmjd2c-knockout ESCs can transit into
self-renewing EpiSCs, these cells fail to form derivatives of the three
primary germ layers, as revealed by their inability to initiate
appropriate gene expression programs. By contrast, Jmjd2c-knockout
cells remain capable of adopting extra-embryonic endoderm-like
phenotypes under permissive conditions. Mechanistically, we show
that Jmjd2c is re-distributed to lineage-specific enhancers in primed
(serum/LIF) as opposed to naïve (2i/LIF) ESCs. Strikingly, Jmjd2c-
bound enhancers are co-occupied by the antagonistic enzyme G9a
(also known as Ehmt2), independently of its silencing H3K9-
modifying activity. We show that Jmjd2c and G9a co-occupancy
coincides with the formation of activating, Med1-containing enhancer
complexes. Loss of Jmjd2c abrogates G9a recruitment at Jmjd2c-
bound distal sites, which correlates with inefficient loading of
mediator-cohesin complexes in ESC-derived EpiSCs and impacts on
gene activation upon lineage specification. Collectively, these data
reveal that Jmjd2c is required for successful gene transcription and
somatic differentiation in pluripotent stem cells, and propose a novel
regulatory role for Jmjd2c in stabilising the assembly of essential
enhancer-protein complexes at the onset of ESC differentiation.
RESULTS
Jmjd2c is required for embryonic stem cell differentiation
towards somatic lineages
Combining genetic deletion and functional assays, we tested
whether Jmjd2c plays a role at the exit of pluripotency. Jmjd2c
mutant and wild-type JM8-ESCs were obtained through the
EUCOMM/IKMC repository (Bradley et al., 2012; Skarnes et al.,
2011), and targeting of both Jmjd2c alleles in Jmjd2c-knockout (E2
and E3) ESC clones was confirmed by long-range PCR and GFP
expression (Fig. S1A-C). Western blotting validated that full-length
Jmjd2c protein expression was completely abolished in Jmjd2c-
knockout samples (Fig. 1A). This was accompanied by a notable
increase in bulk H3K9me2 levels relative to wild type (Fig. 1B,
Fig. S1D), an effect attributed to the loss of Jmjd2c itself in the
continued expression of other H3K9 demethylases and
methyltransferases (Fig. S1D,E). Constitutively Jmjd2c-depleted
E2 and E3 ESC clones grew normally in medium supplemented
with serum plus LIF (Fig. S1F), in agreement with a similar
conditional knockout model (Pedersen et al., 2014). When plated at
low density, these cells also displayed comparable proportion of
undifferentiated colonies relative to their wild-type counterparts
(Fig. 1C), despite reduced expression levels of pluripotency-
associated factors (Fig. S1G). Jmjd2c depletion did not, however,
result in general de-repression of differentiation-associated genes
(Fig. S1H), including those co-bound by Jmjd2c and PRC
complexes at their promoter regions (Das et al., 2014). These data
indicate that constitutive Jmjd2c-knockout ESCs retain a self-
renewing and undifferentiated phenotype in pluripotency culture
conditions.
To assess the effect of Jmjd2c deficiency on differentiation,
Jmjd2c-knockout and wild-type ESCs were induced to form
embryoid bodies (EBs) (Fig. 1D,E). In contrast to the
dispensability of Jmjd2c for ESC self-renewal, Jmjd2c-deficient
cells were unable to properly differentiate into derivatives of the
three germ layers. These cells formed smaller EBs (Fig. 1D) that, in
contrast to wild-type EBs, showed residual expression of the
pluripotency factors Oct4 and Nanog (Fig. 1E, upper panel).
Notably, Jmjd2c-knockout EBs showed impaired expression of the
epiblast marker Fgf5 and several mesoderm, endoderm and
ectoderm germ layer-affiliated genes (Fig. 1E, lower panels).
Importantly, this defect was recapitulated using another loss-of-
function strategy (Fig. S2). Using validated puromycin-selectable
shRNA vectors (Loh et al., 2007), we could indeed stably establish
several Jmjd2c-knockdown E14-ESC clones (Fig. S2A-C). As
Jmjd2c-knockout ESCs, these clones proliferated normally,
showing no incidence of spontaneous differentiation and/or
prominent gene de-repression (Fig. S2D,E). Moreover, we found
that Jmjd2c-knockdown ESCs failed to potently activate brachyury
and Mixl1 upon EB formation, despite evidence for Fgf5 induction
at variable levels in different clones and experiments (Fig. S2F; data
not shown). Collectively, these findings demonstrate that Jmjd2c is
important for the successful differentiation of ESCs into multiple
somatic lineages.
Strikingly, however, Jmjd2c-deficient cells could differentiate
upon LIF withdrawal and addition of all-trans retinoic acid (atRA),
indicating that not all differentiation pathways in ESCs were
compromised in the absence of Jmjd2c. Differentiation was
evidenced by a complete loss of Oct4 expression (Fig. 1F), and
prominent upregulation of Gata6, Gata4, Sox7 and Dab2
transcripts (Fig. 1G), consistent with the preferential acquisition
of a primitive endoderm (PrE)-like phenotype under these
conditions (Artus et al., 2010; Capo-Chichi et al., 2005). In
atRA-treated wild-type ESCs, PrE-like differentiation was marked
by the swift downregulation of Jmjd2c (Fig. 1G, bottom panel),
similar to what was observed upon trophoblast lineage
commitment in vitro (Alder et al., 2010). These findings
corroborate with in vivo studies showing that Jmjd2c expression
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is dynamically lost in the primitive endoderm, while being
retained in the epiblast of peri-implantation embryos (Fig. S3)
(Boroviak et al., 2015; Burton et al., 2013). Hence, Jmjd2c might
be expendable for the formation of extra-embryonic lineages
where it is not normally expressed, an observation that was
substantiated by the successful generation of extra-embryonic
endoderm (XEN) stem cells from Jmjd2c-knockout ESCs
(Fig. S4) (Cho et al., 2012; Kunath et al., 2005; Niakan et al.,
2013). Collectively, our results support a selective requirement for
Jmjd2c during epiblast-derived lineage specification.
Fig. 1. Jmjd2c-knockout ESCs can self-renew but fail to differentiate into somatic lineages. (A) Western blot using anti-Jmjd2c and anti-Jmjd2b antibodies
of whole-cell extracts from wild-type (WT) JM8-ESCs and Jmjd2c-knockout (Jmjd2c-KO) cell lines (E2 and E3). α-Tubulin is used as loading control. (B) Western
blots showing bulk levels of H3K9me2, H3K9me3 and total histone H3 in acid-extracted histone lysates from wild-type and Jmjd2c-KO cells. Signal quantification
is presented relative to wild type. (C) Ability of wild-type and Jmjd2c-KO cells to self-renew. Cells were plated at low density and cultured for 5 days with LIF.
Colonies were scored as undifferentiated, mixed or differentiated based on alkaline phosphatase activity. Data represent mean±s.e.m. of four experiments.
(D) Phase-contrast images of day 9 embryoid bodies (EBs) formed from wild-type and Jmjd2c-KO (E3) ESCs. Scale bars: 100 µm. (E) Expression profiling of
Jmjd2c, pluripotency-associated (Nanog, Oct4), epiblast (Fgf5), mesoderm (brachyury, Mixl1), endoderm (Foxa2) and neuroectoderm (Mash1, Pax3) markers
during EB-mediated differentiation, as assessed byRT-qPCRand normalised to housekeeping genes. Data representmean±s.e.m. of at least three experiments.
*P<0.05; Mann–Whitney U-test at peak time-points. (F) Immunofluorescence staining for Oct4 (green), Gata6 (yellow) and phalloidin (red) in wild-type and
Jmjd2c-KO (E3) ESCs maintained under proliferative conditions or upon 1 µM retinoic acid (atRA) addition and LIF removal for 4 days. Scale bars: 100 µm.
(G) Transcript levels of Gata6, Gata4, Sox7 and Dab2 (PrE markers), Jmjd2c and Fgf5, as assessed during atRA-induced differentiation. Expression is
normalised to housekeeping genes and data show mean±s.e.m. of three experiments. *P<0.05; Mann–Whitney U-test at day 4.
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Lack of transcriptional gene priming and skewed cell fate in
Jmjd2c-deficient epiblast stem cells
To explore the timing of Jmjd2c function in somatic differentiation,
we first examined whether Jmjd2c was required during the transition
from ESC to EpiSC pluripotent states (Guo et al., 2009). Both
Jmjd2c-knockout and wild-type EpiSC lines could be stably
established (Fig. S5). However, during this process, we noticed a
delay in the induction of the early EpiSC markersOtx2 andDnmt3b
(Tesar et al., 2007; Veillard et al., 2014) in Jmjd2c-knockout relative
to wild-type ESCs when treated with activin and fibroblast growth
factor (Fig. S5A). Notably, lower Fgf5 mRNA levels were detected
in stably converted EpiSCs (cEpiSCs) in the absence of Jmjd2c.
Hence, although Jmjd2c-deficient ESCs retain the ability to convert
into EpiSCs, these cells harbour an incomplete/immature epiblast-
like state, which is further suggested by a lack of low-level
transcripts at primed germ layer (brachyury and Foxa2) markers in
Jmjd2c-knockout cEpiSCs (Fig. S5A, lower panel).
To determine whether Jmjd2c deficiency also impacts on the
ability of cEpiSCs to respond to differentiation cues, we compared
the behaviour of Jmjd2c-knockout and wild-type cEpiSCs when
prompted to differentiate towards mesodermal lineages. Here, we
used a protocol adapted from a human ESC differentiation model
(Cheung et al., 2012) to induce early mesodermal (EM) progenitors
and mature lateral plate mesodermal (LPM) and paraxial
mesodermal (PM) cell types (Fig. 2A). Both control EpiSCs and
wild-type cEpiSCs readily acquired an EM-like identity, as typified
by the loss of Fgf5 expression and acquisition of the early primitive
streak marker brachyury at day 1-1.5 post-induction (Fig. 2B). By
contrast, we found that Jmjd2c-knockout cEpiSCs were unable to
efficiently progress into early, brachyury-positive, mesodermal
progenitors, confirming that differentiation blockage occurs at an
early epiblast-like stage in the absence of Jmjd2c.
All three cell lines were further differentiated under LPM and
PM conditions, generating Flk1- and Pdgfrα-expressing cell
populations, respectively, as monitored by flow cytometry on day
4 post-induction (Fig. 2C). Although the wild-type cEpiSC
response closely mirrored that of embryo-derived EpiSCs,
differentiation into mature cell types was blocked in Jmjd2c-
knockout cultures, showing impaired expression of LPM (Kdr/Flk1
and Isl1) and PM (Pdgfra and Meox1) markers. Instead, and
irrespective of LPM and PM conditions, Jmjd2c-knockout cells
induced typical post-implantation extra-embryonic endoderm (Lrp2
and Sparc) but not definitive and pan endodermal (Cxcr4 and
Foxa2) markers (Fig. 2D, right panels). Moreover, these cells
Fig. 2. Skewed differentiation of Jmjd2c-knockout cEpiSCs upon mesoderm induction. (A) Timeline of EpiSC induction towards early mesodermal (EM)
progenitors and mature lateral plate mesoderm (LPM) and paraxial mesoderm (PM) cells. (B) Expression levels of Fgf5 and brachyury in control embryo-derived
EpiSCs (grey), wild-type (black) and Jmjd2c-KO (red) cEpiSCs upon EM induction. Data are normalised to housekeeping genes and expressed relative to control
EpiSCs as mean±s.e.m. of three experiments. *P<0.05; Mann–Whitney U-test. (C) Average percentage (±s.e.m.) of Flk1-positive LPM and Pdgfrα-positive
PM differentiated cells, as monitored by flow cytometry in control, wild-type and Jmjd2c-KO cultures at day 4 post-induction in at least three experiments.
(D) Expression of lateral plate (Kdr/Flk1 and Isl1) and paraxial (Pdgfra and Meox1) mesoderm; extra-embryonic endoderm (Lrp2 and Sparc); and definitive
(Cxcr4) and pan (Foxa2) endoderm markers in wild-type and Jmjd2c-KO differentiated cells under LPM/PM conditions. Data are normalised to housekeeping
genes and expressed relative to wild type (day 0) as mean±s.e.m. of three experiments. *P<0.05; Mann–Whitney U-test. (E) Phase-contrast images of LPM and
PM wild-type and Jmjd2c-KO cultures. Scale bars: 100 µm.
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acquired an adhesive, polarised epithelium-like morphology
(Fig. 2E) and stained positive for E-cadherin (Fig. S6) similar to
what is observed upon BMP4-induced differentiation of XEN cells
(Artus et al., 2012; Paca et al., 2012). Collectively, our findings
suggest that, in the absence of Jmjd2c, epiblast cell fate might
default towards extra-embryonic endoderm-like derivatives, as
tested here upon mesodermal lineage induction.
De novo Jmjd2c recruitment to H3K4me1/me2-rich lineage-
specific enhancers in primed embryonic stem cells
We have shown that Jmjd2c loss in ESCs is sufficient to inhibit
somatic differentiation, despite Jmjd2c being normally
downregulated upon induction (Fig. 1E, upper panel). This
suggests an important role for Jmjd2c in undifferentiated ESCs
either in preserving their multi-lineage potential or in mediating the
transition from pluripotent ESC to differentiated states. To address
the molecular basis for the skewed differentiation of Jmjd2c-
knockout ESCs, we mapped and compared Jmjd2c DNA-binding
sites by ChIP-seq in naïve (2i/LIF) and primed (serum/LIF) ESCs
(Marks et al., 2012). To achieve this, E14-ESC clones stably
expressing Flag-tagged Jmjd2c were generated (ESCFV-Jmjd2c-WT,
Fig. S7), and expanded in either condition prior to anti-Flag ChIP
(Fig. S8A,B).
In 2i/LIF, over 70% of Jmjd2c peaks were detected within 1 kb of
the transcriptional start sites (TSS) (Fig. 3A), as previously reported
(Pedersen et al., 2014). Strikingly, however, Jmjd2c genomic
distribution was altered during the priming of ESCs for
differentiation. Substantially more Jmjd2c peaks (45,485 versus
20,377; FDR<0.0001) were detected in serum/LIF relative to 2i/LIF
conditions. Moreover, we found that the majority of the peaks
specific to the serum/LIF state were located more than 1 kb away
from the TSS interval, hereafter referred to as distal peaks (Fig. 3A;
Fig. S8C). This trend was recapitulated by interrogating an
independent ChIP-seq dataset (Fig. S8D) (Das et al., 2014).
Importantly, we identified that the sets of genes targeted by Jmjd2c
in the two ESC states were largely overlapping, as revealed using
gene annotation analysis (Fig. 3B). Hence, these findings uncover
that, in 2i/LIF, Jmjd2c primarily binds to TSS regions, yet
additionally occupies distal regions affiliated with the same cohort
of genes in serum/LIF, as further validated at selected (Fgf5 and
brachyury) loci by ChIP-qPCR on endogenous Jmjd2c protein in
naïve (2i/LIF) and primed (serum/LIF) wild-type and Jmjd2c-
knockout ESCs (Fig. S8E-G).
Jmjd2c-bound distal peaks most closely overlapped with
H3K4me1-rich sites (Fig. 3C), which typically define enhancers
(Creyghton et al., 2010; Zentner et al., 2011). As expected, Jmjd2c-
bound TSS regions were preferentially decorated with H3K4me3,
whereas H3K4me2 could be detected at both TSS and distal peaks.
Given that Jmjd2c can bind both H3K4me2 and H3K4me3 in a
Tudor domain-dependent manner (Pedersen et al., 2014), we asked
whether Jmjd2c recruitment at enhancers might be at least partly
mediated via H3K4me2 recognition. Combining mutagenesis and
ChIP-qPCR analyses, we showed that Jmjd2c binding was
abrogated at TSS and distal regions in ESCs expressing a mutant
version of Jmjd2c lacking its two Tudor domains (ESCsFV-Jmjd2c-ΔT)
(Fig. 3D; Fig. S7D), indirectly validating H3K4-dependent Jmjd2c
DNA binding. Strikingly, however, FV-Jmjd2c-ΔT binding was
selectively retained at ESC-specific (Esrrb and Klf4) enhancers
(Fig. 3D, bottom panel), suggesting a different mode of Jmjd2c
recruitment at these sites possibly via cooperation with additional
enhancer-bound proteins, including Jmjd2b and Nanog, as
previously suggested (Das et al., 2014).
Active and poised enhancers can be distinguished genome-wide
by the presence or absence of p300-mediated H3K27ac marks
(Creyghton et al., 2010; Zentner et al., 2011). Interestingly, we
found that 85% of Jmjd2c-bound distal peaks harboured low or no
H3K27ac deposition (Fig. 3E), indicating that Jmjd2c is prevalently
recruited to poised enhancers in serum/LIF. Known motif sequence
enrichment analysis at these sites disclosed a high incidence of
motifs for differentiation-associated factors, such as brachyury,
Gata3 and Atoh1 (Fig. 3F), typifying tissue-specific enhancers
activated later on during development. Concordantly, Gene
Ontology analysis revealed significant enrichment for
developmental and somatic differentiation processes at Jmjd2c-
bound, H3K27ac-low sites (Fig. 3G). These findings support a role
for Jmjd2c in promoting differentiation into derivatives of the three
primary germ layers. Taken together, our findings reveal that
Jmjd2c is recruited in a timely manner to lineage-specific enhancers
during ESC priming for differentiation.
The antagonistic enzymes Jmjd2c and G9a are co-enriched
at active and poised enhancers independently of H3K9-
modifying activities
Consistent with its H3K9-demethylase activity (Cloos et al., 2006;
Whetstine et al., 2006), we showed that constitutively depleting
Jmjd2c in ESCs leads to a noticeable increase in bulk H3K9me2
levels (Fig. 1B, Fig. S1D). Deposition of H3K9 and DNA
methylation are known mechanisms operating in extra-embryonic
tissues and derived stem cells to prevent the expression of somatic,
lineage-specific genes (Alder et al., 2010; Senner et al., 2012). In
light of the skewed differentiation of Jmjd2c-knockout ESCs
towards extra-embryonic fates, we thus asked whether Jmjd2c
occupancy might antagonise the acquisition of repressive marks in
pluripotent stem cells.
At the chromosomal level, G9a-mediated H3K9me2 deposition
encompasses large domains yet is depleted at the TSS regions of
active and lineage-specific genes in ESCs (Lienert et al., 2011).
We confirmed genome-wide that Jmjd2c and H3K9me2 are
mutually exclusive across Jmjd2c-bound TSS regions, whereas
G9a and H3K9me2 are confined to regions flanking Jmjd2c peak
summits, as demonstrated using heatmap distributions and
Pearson’s correlation coefficients (Fig. 4A,B, left panels). In
striking contrast, however, Jmjd2c and G9a largely overlapped
across enhancer regions in the absence of H3K9me2 deposition
(Fig. 4A,B, right panels), as observed at both active and poised
Jmjd2c-bound distal sites (Fig. S9). The colocalisation of the two
antagonistic enzymes Jmjd2c and G9a at enhancers suggests a
possible counteracting mechanism in the control of gene
expression. Loss of Jmjd2c, however, did not lead to increased
levels of H3K9me2 and de novo DNA methylation (Fig. 4C; data
not shown), as examined at the locus level across Fgf5 and
brachyury regulatory regions in Jmjd2c-knockout ESCs, and in
derived cEpiSCs and induced-mesodermal progenitors where Fgf5
and brachyury activation is respectively inhibited in the absence of
Jmjd2c (Fig. 2). These data strongly suggest that, in contrast to
what we hypothesised, the failure of Jmjd2c-knockout cells to
differentiate towards somatic derivatives is not due to a lack of
Jmjd2c-mediated protection against the acquisition of repressive
marks at Jmjd2c-bound gene targets.
Surprisingly, we found that the highest levels of G9a were
detected at active (H3K27ac-high) Jmjd2c-bound distal sites
(Fig. S10A, left panel), as exemplified at Esrrb and Klf4 loci
(Fig. S10B,C). Moreover, G9a significantly overlapped with known
enhancer-associated factors, including p300, Oct4 and the subunits
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Fig. 3. Jmjd2c preferentially overlaps with H3K4me1/me2-rich lineage-specific enhancers in primed ESCs. (A) Numbers of Jmjd2c peaks located within
1 kb of transcriptional start sites (TSS) or outside this interval (distal) in 2i/LIF and serum/LIF. (B) Venn diagrams indicating the overlap of Jmjd2c-bound TSS
and distal peaks in serum/LIF with at least one peak in 2i/LIF (minimum overlap=1 bp); overlap of the nearest gene to Jmjd2c peaks in the two conditions (right
panel). (C) Density heatmaps of H3K4me3/2/1 and Jmjd2c levels across a 10 kb window centred at TSS and distal Jmjd2c-bound regions in serum/LIF.
(D) Enrichment levels for full-length Jmjd2c (FV-Jmjd2c-WT) and a mutant form of Jmjd2c lacking Tudor domains (FV-Jmjd2c-ΔT) at TSS and enhancer sites of
active (Esrrb and Klf4) and lineage-specific (Fgf5 and brachyury) genes in ESCs. Fold enrichment is relative to control cells (empty vector; dotted line). Data
represent mean±s.e.m. of three experiments. Background level is confirmed at an intergenic region. (E) Average density plots and heatmaps of H3K27ac,
H3K4me1 and Jmjd2c levels across a 10 kb window centred at Jmjd2c-bound distal sites in serum/LIF. Peaks are sorted according to H3K27ac levels using a
k-means clustering algorithm. (F) Motifs identified among overrepresented binding sequences at H3K27ac-low Jmjd2c distal peaks. (G) Top 10 most significant
biological functions of genes associated with H3K27ac-low Jmjd2c distal peaks.
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of mediator (Med1) and cohesin (Smc1a) complexes at these sites in
ESCs (Fig. 5A,B). Lower yet detectable G9a enrichment, with
peaks closely aligned with Jmjd2c, p300, Oct4, Med1 and Smc1a,
also marked poised (H3K27ac-low) Jmjd2c-bound enhancers
(Fig. 5A, lower panels), as illustrated at Fgf5 and brachyury loci
(Fig. S10D-E). The detection of differential G9a enrichment levels
at ESC-specific and transcriptionally primed loci was furthermore
verified by ChIP-qPCR in JM8-ESCs (Fig. 5C), and validated in
control and G9a-knockout ESCs, where G9a precipitation was
abolished, as expected (Fig. S11A-C). Interestingly, although
Jmjd2c binding remained unaltered in G9a-knockout ESCs, G9a
was lost at Fgf5 and brachyury enhancers in the absence of Jmjd2c
(Fig. S11D), suggesting a possible role for Jmjd2c in facilitating
G9a binding. Jmjd2c-G9a co-occupancy was furthermore supported
by the identification of a physical interaction between Jmjd2c and
G9a/GLP (Fig. 5D), and their simultaneous detection at the same
enhancer fragments in sequential ChIP (re-ChIP) assays
(Fig. S11E). Importantly, Jmjd2c and G9a also interact with
Med1 (Fig. S11F-G), further implying that Jmjd2c-G9a co-
occupancy might coincide with the assembly of activating protein
mega-complexes at enhancers. Taken together, our findings unveil
Jmjd2c and G9a as novel enhancer-associated factors, and
demonstrate that these molecules are co-recruited genome-wide to
active and poised enhancers in ESCs independently of their H3K9-
modifying activities.
Jmjd2c facilitates the assembly of essential enhancer-
protein complexes in ESC-derived epiblast stem cells
We observed that, similar to H3K4me1, Jmjd2c pre-marks a large
panel of tissue-specific enhancers in ESCs prior to gene activation
and lineage specification (Fig. 3). We therefore hypothesised that,
instead of protecting regulatory regions from the acquisition of
repressive marks, Jmjd2c might facilitate and/or stabilise the
assembly of enhancer-associated proteins, including G9a, at
the onset of differentiation. To explore this, we compared the
enrichment profiles of Jmjd2c, p300, Oct4, G9a, Med1 and Smc1a
in Jmjd2c-knockout and wild-type ESC-derived cEpiSCs by ChIP-
qPCR. For this analysis, we focussed on the previously delineated
Fgf5 poised enhancer (PE) in ESCs, or on newly established (E1 and
E3) enhancers produced by Fgf5 activation in post-implantation
epiblast-like cells (Fig. 6A) (Buecker et al., 2014). These sites are
co-occupied by Jmjd2c and G9a, as verified in wild-type cEpiSCs
(Fig. 6B, left panel).
All three Fgf5 enhancer (PE, E1 and E3) elements examined were
similarly bound by Oct4 and p300, and harboured high levels of
p300-mediated H3K27ac deposition in wild-type and Jmjd2c-
knockout cEpiSCs (Fig. 6B; data not shown). This suggests that
Jmjd2c is not required for the binding of the pioneer transcription
factor Oct4 and/or for the establishment of permissive chromatin at
enhancers. Despite similar detection of protein levels in wild-type and
knockout samples (Fig. S12A), we observed that Jmjd2c loss
Fig. 4. G9a is enriched at distal Jmjd2c-bound sites independently of its H3K9-modifying activity. (A) Heatmap distributions (i.e. binned mean ChIP-seq
read density) of Jmjd2c, G9a (Mozzetta et al., 2014), H3K9me2 (1) (Liu et al., 2015) and H3K9me2 (2) (Das et al., 2014) across Jmjd2c-bound TSS and distal
sites. Each ChIP-seq experiment is adjusted for sequencing depth and normalised to respective input. Colour key indicates enrichment levels from low to high.
(B) Heatmap showing Pearson correlation between Jmjd2c, G9a and H3K9me2 distributions across Jmjd2c-bound TSS and distal sites. Colour key indicates
correlation coefficient from low to high. (C) Enrichment levels for H3K9me2 at TSS, distal/enhancer and Jmjd2c-free flanking regions of Fgf5 and brachyury,
as determined by ChIP-qPCR in wild-type and Jmjd2c-KO ESCs and cEpiSCs, and upon cEpiSC mesodermal induction. Data are relative to flanking regions
(dotted line) and are shown as mean±s.e.m. of three experiments. Magea2 TSS is used as positive control.
573
STEM CELLS AND REGENERATION Development (2017) 144, 567-579 doi:10.1242/dev.142489
D
E
V
E
LO
P
M
E
N
T
abrogated G9a recruitment, as seen at the ESC stage (Fig. S11D, right
panel), and furthermore destabilised the loading of the essential
enhancer-associated factors Med1 and Smc1a (Fig. 6B), potentially
impeding Fgf5 expression in Jmjd2c-knockout cEpiSCs (Fig. S5A).
Remarkably, we identified that G9a, Med1 and Smc1a binding were
similarly compromised at poised enhancers of germ layer markers
(Zic1 and brachyury) prior to gene activation (Fig. S12B). Based on
these findings, we propose that inefficient assembly of activating
protein complexes at poised and newly established enhancers could
account for the impaired activation of lineage-affiliated genes that we
have observed upon somatic differentiation in Jmjd2c-knockout
pluripotent stem cells (Figs 1E and 2).
Fig. 5. Jmjd2c and G9a co-occupy active and poised enhancers in ESCs. (A) Average density plots and heatmaps showing enrichment levels for Jmjd2c,
G9a, p300, Oct4, Med1 and Smc1a within a 10 kb window centred at H3K27ac-high (light blue) and H3K27ac-low (dark blue) Jmjd2c distal peaks. Scales are
adjusted to maximum peak intensity for each dataset. (B) G9a peaks intersecting with Jmjd2c-distal H3K27ac-high sites are selected for this analysis. Depicted
are the numbers of G9a/Jmjd2c peaks overlapping with Med1/p300, Med1/Oct4 and Med1/Smc1a (maximum gap 200 bp). P-values are calculated using
hypergeometric tests. (C) Enrichment levels for H3K27ac, G9a and Med1 at enhancers of active (Esrrb and Klf4) and lineage-specific (Fgf5 and brachyury)
genes, as assessed by ChIP-qPCR. Data are relative to an intergenic region (dotted line) and represent mean±s.e.m. of three experiments. (D) (Left) G9a and
GLP immunoprecipitations performed in nuclear fractions of ESCs expressing Flag-tagged Jmjd2c (FV-Jmjd2c). Input corresponds to control ESCs. Lanes were
cropped and repositioned for clarity. (Middle and right panels) GLP immunoprecipitation performed in nuclear fractions of wild-type, Jmjd2c-KO and full-length
Jmjd2c rescue ESCs. Interactions are visualised using immunoblotting. Data represent duplicate experiments.
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DISCUSSION
In this study, we have identified a novel regulatory function for
Jmjd2c at tissue-specific enhancers during ESC priming for
differentiation. We show that Jmjd2c is required for successful
multi-lineage differentiation, as assessed by EB formation. In the
absence of Jmjd2c, EBs were smaller and ineffective at inducing
expression of differentiation-associated genes, including early
markers of the three mesoderm, endoderm and ectoderm lineages.
Moreover, we established that ESC differentiation was impeded or
stalled at an early post-implantation epiblast-like stage. Indeed,
while Jmjd2c-knockout ESCs could transit into self-renewing
cEpiSCs, these cells failed to establish a functionally primed state –
a point that was reinforced here by their inability to further progress
into mesodermal progenitors. By contrast, we found that Jmjd2c-
knockout ESCs could readily differentiate into primitive endoderm-
like derivatives under permissive conditions, as recently confirmed
in triple Jmjd2abc-knockout models (Pedersen et al., 2016).
Interestingly, however, among the three Jmjd2 family members,
Jmjd2c is uniquely downregulated in the primitive endoderm of the
developing blastocyst, while being upregulated in the epiblast at
peri-implantation times (Fig. S3) (Boroviak et al., 2015). This
in vivo expression pattern most closely concurs with a primary role
for Jmjd2c in the epiblast, while being dispensable for the formation
of extra-embryonic tissues, as demonstrated in this study using ESC,
EpiSC and XEN in vitro models.
We confirmed that Jmjd2c knockout is not detrimental to ESC
proliferation and the maintenance of an undifferentiated phenotype
upon prolonged culture (Pedersen et al., 2014), a conclusion
here extended to ESC-derived EpiSCs. These results reiterate
the robustness of pluripotent stem cell self-renewal, most likely
reflecting compensation mechanisms among related transcriptional
regulators, including Jmjd2 family members (Pedersen et al., 2016).
These results, however, contrast with earlier studies showing that
shRNA-mediated Jmjd2c depletion led to spontaneous ESC
differentiation and/or de-repression of many lineage-specific
markers (Das et al., 2014; Loh et al., 2007). The discrepancies
between these differing phenotypes could relate to differences in
genetic backgrounds, culture conditions and the use of different
knockdown constructs versus the study of constitutive knockout
ESC models. Importantly, our conclusion that Jmjd2c-depleted
ESCs self-renew normally yet fail to properly differentiate into
epiblast-derived progenitors is based on concurring functional
characterisation of Jmjd2c-knockout and -knockdown models, thus
ruling out off-target effects commonly associated with shRNA
approaches. Previously published studies of Jmjd2c function in
ESCs (Das et al., 2014; Loh et al., 2007; Pedersen et al., 2014) did
not investigate the impact of Jmjd2c depletion on the differentiation
abilities of ESCs upon EB formation and lineage-specific induction,
which precludes further comparison.
Interestingly, ectopically expressing Jmjd2c in ESCs also led to
differentiation inhibition upon EB formation (data not shown). This
finding, together with Jmjd2c being normally downregulated during
this process, points to an important role for this protein at the onset
of differentiation. Accordingly, we found that Jmjd2c is recruited in
a timely manner to lineage-specific enhancers upon ESC priming
for differentiation. By directly comparing Jmjd2c genome-wide
DNA-binding sites in 2i/LIF and serum/LIF, we confirmed that
Jmjd2c is prevalently bound to H3K4me3-rich TSS regions of
Fig. 6. Assembly of enhancer-protein complexes is
destabilised in the absence of Jmjd2c in ESC-derived
EpiSCs. (A) Mapping of poised (PE) and epiblast-specific
enhancer sites (E1-E4) at Fgf5 locus (Buecker et al.,
2014). (B) Enrichment levels for Jmjd2c, p300, Oct4,
G9a, Med1 and Smc1a at indicated sites as assessed by
ChIP-qPCR in wild-type and Jmjd2c-KO cEpiSCs. Fold
enrichment is relative to an intergenic region (dotted line)
and represents mean±s.e.m. of three experiments.
*P<0.05; Mann–Whitney U-test.
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active and differentiation-associated genes in 2i/LIF. Strikingly,
however, we identified that a significant fraction of serum/LIF-
specific Jmjd2c-binding sites maps away from TSS regions,
overlapping with H3K4me1/me2-rich enhancer regions in the
vicinity of the same cohort of gene targets. Although Jmjd2c
binding is less abundant at distal relative to TSS sites (Fig. S8 and
Fig. S10), we confirmed that Jmjd2c is similarly recruited, at least in
part, to enhancers and cognate promoters via its Tudor domains,
most likely by recognition of H3K4me2/1 and H3K4me3,
respectively (Pedersen et al., 2014). This corroborates with
Jmjd2c detection in H3K4me3- and H3K4me1-coupled proteome
datasets, as recently reported (Engelen et al., 2015). Given that
regulatory regions nucleate the binding of numerous transcriptional
regulators and co-factors, resident molecules might also contribute
to Jmjd2c recruitment via protein-protein interaction at these sites.
Remarkably, however, Jmjd2c was found similarly enriched at
active and pre-marked (poised) enhancers in serum/LIF (Fig. 5),
suggesting that Jmjd2c could act as a molecular platform for the
recruitment of enhancer constituents. In particular, we asked
whether the loss of Jmjd2c in ESCs might impact on Oct4 and
p300 re-distribution at newly activated (Fgf5) enhancer sites upon
ESC-to-EpiSC conversion. Binding of Oct4, p300 and p300-
mediated H3K27ac deposition were, however, retained at Fgf5 in
Jmjd2c-knockout cEpiSCs. Instead, we established that Jmjd2c was
required for the proper binding of Med1 and Smc1a at active (Fgf5)
and poised enhancers in epiblast-like cells (Fig. 6 and Fig. S12). A
facilitating role for Jmjd2c in the assembly of activating enhancer-
protein complexes was also supported by the ability of Jmjd2c to
physically interact with G9a and Med1 in ESCs. Together, these
findings suggest that, in the absence of Jmjd2c, inefficient loading
of essential mediator-cohesin complexes at lineage-specific
enhancers impairs the activation of affiliated genes, accounting
for the differentiation defect observed in Jmjd2c-knockout cells.
Given the established role of mediator and cohesin in bridging
enhancers and core promoters (Kagey et al., 2010), we speculate that
Jmjd2c recruitment to enhancers might coincide and/or contribute
to DNA looping events prior to gene activation and lineage
specification (Fig. 7). In line with this model, we find that Jmjd2c-
bound distal peaks closely align with promoter-enhancer interaction
sites, as shown in the vicinity of Foxa2 in ESCs (Fig. S13).
Interestingly, we note that the stability of all Jmjd2c-bound
promoter-enhancer interactions observed across the genome is
significantly enhanced in serum/LIF when compared with 2i/LIF
(CHiCAGO score analysis, P-value 2.446×10−12; O.J. and H.G.S.,
unpublished), correlating with Jmjd2c re-distribution to poised
enhancers during ESC priming for differentiation. However, and
given that ChIP and Hi-C approaches commonly employ
crosslinked chromatin, it remains unclear whether the increased
detection of Jmjd2c at enhancers might be the cause or the result of
stabilised promoter-enhancer interactions in serum/LIF.
An intriguing finding arising from this study is the co-recruitment
of the H3K9-methyltransferase G9a to Jmjd2c-bound distal peaks in
ESCs. Contrasting with its canonical role in gene silencing (Feldman
et al., 2006; Mozzetta et al., 2014), highest G9a co-enrichment levels
were unexpectedly observed at ESC-specific, Jmjd2c-bound
enhancers, suggesting that G9a/Jmjd2c co-enrichment might
coincide with the formation of activating complexes. Moreover,
and similar to Oct4, p300, Med1 and Smc1a, G9a was also present at
lineage-specific, Jmjd2c-bound enhancers, although at reduced levels
in ESCs. In the absence of Jmjd2c, G9a binding was destabilised, as
also demonstrated in ESC-derived cEpiSCs along with Med1 and
Smc1a. Interestingly, G9awas found to be capable of interacting with
Jmjd2c, Med1 or CDYL, suggesting that G9a can form both
activating and repressive complexes in ESCs (Fritsch et al., 2010).
This is in agreement with previous reports showing that G9a is co-
recruited and interacts with either the co-activator Med1 or the co-
repressor Jarid1 in a mutually exclusive manner at β-globin genes
during haematopoiesis (Chaturvedi et al., 2012; Shankar et al., 2013).
Remarkably, and consistent with a dual role for G9a in regulating
gene expression, we find that Jmjd2c-G9a co-bound targets are
significantly enriched among differentially expressed genes in G9a-
knockout ESCs (Mozzetta et al., 2014) and E8.5 embryos (Auclair
et al., 2016), showing clear evidence for both gene upregulation and
downregulation in vitro and in vivo (Fig. S14). Notably, genes
associated with developmental processes are prevalently
downregulated in E8.5 embryos in the absence of G9a as
previously documented (Auclair et al., 2016; Mozzetta et al.,
2014). However, the mechanisms underlying the action of G9a as
repressor and activator in ESCs and in other cellular contexts
(Chaturvedi et al., 2012; Shankar et al., 2013) remain unknown.
Despite a global increase in H3K9me2 levels in the absence of
Jmjd2c, we did not detect any aberrant acquisition of H3K9 and
DNA methylation at Jmjd2c/G9a co-bound lineage-affiliated genes
in Jmjd2c-knockout ESCs, in cEpiSCs or upon lineage specification
(Fig. 4; data not shown). This argued against a role for Jmjd2c in
continually removing G9a-mediated H3K9me2 deposition,
implying novel histone-independent roles for Jmjd2c and G9a at
tissue-specific enhancers. Although the precise molecular interplays
between the two molecules need to be fully deciphered, we note that
G9a automethylation sites, which anchor the binding of repressive
complexes (Ruan et al., 2012), were previously identified as
potential targets for Jmjd2c-mediated demethylation (Ponnaluri
et al., 2009). Whether demethylation of G9a by Jmjd2c via its
catalytic domain is a prerequisite for interaction with activating
complexes needs to be studied. More generally, further elucidating
how Jmjd2c and other histone demethylases might act as key post-
translational regulators to promote the assembly of activating
enhancer-protein complexes could indeed provide novel important
insights into the regulation of enhancer activity and gene expression
in stem cells and development.
Fig. 7. Proposed model: assembly of activating Jmjd2c-
G9a centred enhancer-protein complexes. Jmjd2c and
G9a co-occupy poised (lineage-specific) enhancers in
primed ESCswhere they stabilise the assembly of mediator-
cohesin complexes (Kagey et al., 2010) that are necessary
for the formation of DNA loops and for potent gene activation
at the exit of pluripotency and upon differentiation.
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MATERIALS AND METHODS
Cell culture
Mouse ESCs were cultured as previously described (Alder et al., 2010) with
10% FBS (serum), LIF or adapted to serum-free conditions (N2B27 with
1 μM PD0325901, 3 μM CHIR99021 and LIF), as described previously
(Ying et al., 2008). Generation of ESC lines are described in the
supplementary Materials and Methods, and primers used for genotyping/
cloning are listed in Tables S2 and S3.
ESC differentiation was induced in embryoid bodies (EBs) (ultra-low
attachment plates, Corning, in 5% FBS without LIF) or with addition of
1 µM all-trans retinoic-acid (atRA) in 5% FBS without LIF. For mesoderm
differentiation, EpiSCs were cultured in FLyBmedia (bFGF, LY294002 and
BMP4) for 36 h followed by either FB40 (bFGF and BMP4) or FLyWLDN
(bFGF, LY294002, Wnt3a and LDN193189) media as previously described
(Cheung et al., 2012). Full media composition and generation of cEpiSCs
are outlined in the supplementary Materials and Methods.
Quantitative PCR
RNA was isolated with the RNeasy mini kit (Qiagen) and reverse-
transcribed using SuperScript II (Invitrogen). cDNA/DNA was amplified
with KicQstart SYBR Green PCR Mastermix (Sigma). Details and primer
sequences are listed in the supplementary Materials and Methods and
Table S4.
Immunofluorescence staining
Cells fixed with 4% paraformaldehyde were permeabilised/blocked for
30 min in 0.4% TritonX-100 and 10% serum. Primary antibody (see
Table S1) incubation occurred overnight at 4°C. Fluorophore-conjugated
secondary antibodies (ThermoFisher) were incubated for 1 h. Fluorescence
was visualised on a SP5 Leica confocal microscope or a fluorescent/
brightfield microscope. For further details, see supplementary Materials and
Methods.
Flow cytometry analysis
Cells were harvested using cell dissociation buffer (Gibco), blocked in 2%
FBS and analysed on an Accuri C6 Flow cytometer. For details on the
antibodies used, see supplementary Materials and Methods.
RNA-seq analysis
Computational analysis on previously published RNA-seq datasets
generated in G9a-knockout and wild-type embryos and ESCs are
described in the supplementary Materials and Methods.
Immunoblotting, immunoprecipitation, ChIP and ChIP-seq
Whole-cell lysates and acid-extracted histones (Shechter et al., 2007) were
resolved on SDS-PAGE gels and transferred into PVDF membranes (GE
Healthcare). Immunoprecipitation and chromatin immunoprecipitation
(ChIP) were performed as previously described (Battisti et al., 2016;
Frank et al., 2001; Fritsch et al., 2010). Experimental details and information
about computational analysis are outlined in the supplementary Materials
and Methods. Primers used for the ChIP can be found in Tables S5 and S6.
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